LRCX
59
-5
XEL
62
2
AAP
29
2
SPG
68
4
WU
54
2
AEE
46
3
TDC
52
-21
MSI
57
2
EW
48
6
TEL
79
4
PLD
56
5
FTI
94
2
GWW
51
-4
EXPD
39
-6
ZION
57
-2
CMS
67
2
HOG
38
3
EFX
69
3
OMC
70
2
PFE
40
-2
LRCX
59
-5
XEL
62
2
AAP
29
2
SPG
68
4
WU
54
2
AEE
46
3
TDC
52
-21
MSI
57
2
EW
48
6
TEL
79
4
PLD
56
5
FTI
94
2
GWW
51
-4
EXPD
39
-6
ZION
57
-2
CMS
67
2
HOG
38
3
EFX
69
3
OMC
70
2
PFE
40
-2
Financhill
Back

ProShares UltraShort Nasdaq Biotech Stock Predictions

Master the Market: The Formula for a 96.3% Win Rate Revealed!

Act now!
Sell
25

BIS
ProShares UltraShort Nasdaq Biotech

Last Price:
18.14
Seasonality Move:
-12.5%

7 Day Trial

ALL ACCESS PASS

$ 7

America's Final Republican President

Click here to see his 2024 election prediction.

ProShares UltraShort Nasdaq Biotech Stock Forecast

  • Over the next 52 weeks, ProShares UltraShort Nasdaq Biotech has on average historically fallen by 28.1% based on the past 14 years of stock performance.
  • ProShares UltraShort Nasdaq Biotech has fallen lower in 12 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 85.71%
  • Is ProShares UltraShort Nasdaq Biotech Stock Undervalued?
    The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $18.02. The Score for BIS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • BIS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will ProShares UltraShort Nasdaq Biotech Stock Go Up Next Year?

  • Over the next 52 weeks, ProShares UltraShort Nasdaq Biotech has on average historically fallen by 28.1% based on the past 14 years of stock performance.

ProShares UltraShort Nasdaq Biotech Stock Rating

Sell
25
ProShares UltraShort Nasdaq Biotech (BIS) is a Sell

Is ProShares UltraShort Nasdaq Biotech overpriced?

  • ProShares UltraShort Nasdaq Biotech has fallen lower in 12 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 85.71%

ProShares UltraShort Nasdaq Biotech Stock Price History

Is BIS stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIS is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
26.51
52-Week Low:
16.37

Prediction Charts

Market Cap:
0
Price in USD:
18.02
Volume:
380
Beta:
-1.69

Technical Analysis

SMA50:
18.56
SMA100:
18.29
SMA200:
20.36
52-Wk Change:
-5.41%

Stock Predictions

  • Is ProShares UltraShort Nasdaq Biotech stock public?
    Yes, ProShares UltraShort Nasdaq Biotech is a publicly traded company.
  • What is the ProShares UltraShort Nasdaq Biotech stock quote today?
    The ProShares UltraShort Nasdaq Biotech stock price is 18.02 USD today.
  • How to buy ProShares UltraShort Nasdaq Biotech stock online?
    You can buy ProShares UltraShort Nasdaq Biotech shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-18 20.67 20.98 20.98 20.54
Apr-19 20.90 20.90 21.10 20.87
Apr-22 20.74 20.48 20.74 20.13
Apr-23 20.24 19.94 20.24 19.71
Apr-24 19.79 20.09 20.15 19.79
Apr-25 20.31 20.58 20.88 20.30
Apr-26 20.70 20.24 20.74 20.11
Apr-29 20.08 19.54 20.08 19.35
Apr-30 19.64 19.96 19.96 19.64
May-1 20.04 19.11 20.04 18.82
May-2 19.10 18.59 19.13 18.50
May-3 17.86 17.99 18.08 17.76
May-6 17.83 18.10 18.22 17.83
May-7 18.00 18.02 18.02 18.00

ProShares UltraShort Nasdaq Biotech Earnings

Data Unavailable

ProShares UltraShort Nasdaq Biotech Forecast Revenue Growth

Data Unavailable

* ProShares UltraShort Nasdaq Biotech stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.